Enhancement of Gemcitabine-Induced Apoptosis by Restoration of p53 Function in Human Pancreatic Tumors
β Scribed by Cascalló, Manel; Calbó, Joaquim; Capellà, Gabriel; Fillat, Cristina; Pastor-Anglada, Marçal; Mazo, Adela
- Book ID
- 120518175
- Publisher
- S. Karger AG
- Year
- 2005
- Tongue
- English
- Weight
- 741 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0030-2414
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background. In the majority of human cancers, the tumor suppressor activity of p53 is impaired because of mutational events or interactions with other proteins (ie, MDM2). The loss of p53 function is responsible for increased aggressiveness of cancers, while tumor chemoresistance an
Gemcitabine, a cytidine nucleoside analogue, has schedule-dependent antitumor activity in vitro and in vivo. Gemcitabine also has dose-and time-dependent radiosensitization properties in vitro. Thus it may have therapeutic application in combination with radiation. The aims of this study were to inv